Horizon Therapeutics PLC (BSP:H1ZN34)
R$ 57.24 1.92 (3.47%) Market Cap: 130.73 Bil Enterprise Value: 131.98 Bil PE Ratio: 45.18 PB Ratio: 5.01 GF Score: 61/100